Search research articles
Contact Us
Filters
Showing results (31-40 of 426) with videos related to
Page
of 43
Sort By:
Immunology
|
November 1, 1981
The detection and characterization of a membrane protein with Factor B-like activity on human lymphoid cells
P Woo, P J Lachmann
European Journal of Immunology
|
February 1, 1975
The failure to show a necessary role for C3 in the in vitro antibody response
H Waldmann, P J Lachmann
Clinical and Experimental Immunology
|
July 1, 1975
The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation
P J Lachmann, L Halbwachs
Scandinavian Journal of Immunology
|
January 1, 1976
Factor B of the alternative complement pathway on human lymphocytes
L Halbwachs, P J Lachmann
Immunological Reviews
|
January 7, 1998
Complement and immunity to viruses
P J Lachmann, A Davies
Clinical and Experimental Immunology
|
November 1, 1979
Conglutinin binding polyethylene glycol precipitation assay for immune complexes
M Macanovic, P J Lachmann
Clinical and Experimental Dermatology
|
September 4, 2020
The systemic autoinflammatory disorders for dermatologists. Part 2: disease examples
J Oldham, H J Lachmann
Clinical and Experimental Immunology
|
January 1, 1977
Haemolytic assays in agarose plates for components of the classical complement pathway: interference by the alternative pathway
A Martin, P J Lachmann
European Journal of Immunology
|
August 1, 1988
The regulation of IgG subclass production in man: low serum IgG4 in inherited deficiencies of the classical pathway of C3 activation
P Bird, P J Lachmann
European Journal of Immunology
|
March 1, 1975
The failure to show a necessary role for C3 in the in vitro antibody response
H Waldmann, P J Lachmann
Page
of 43
Search research articles
Search
Showing results (31-40 of 426) with videos related to
Sort By:
Page
of 43
Immunology
|
November 1, 1981
The detection and characterization of a membrane protein with Factor B-like activity on human lymphoid cells
P Woo, P J Lachmann
European Journal of Immunology
|
February 1, 1975
The failure to show a necessary role for C3 in the in vitro antibody response
H Waldmann, P J Lachmann
Clinical and Experimental Immunology
|
July 1, 1975
The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation
P J Lachmann, L Halbwachs
Scandinavian Journal of Immunology
|
January 1, 1976
Factor B of the alternative complement pathway on human lymphocytes
L Halbwachs, P J Lachmann
Immunological Reviews
|
January 7, 1998
Complement and immunity to viruses
P J Lachmann, A Davies
Clinical and Experimental Immunology
|
November 1, 1979
Conglutinin binding polyethylene glycol precipitation assay for immune complexes
M Macanovic, P J Lachmann
Clinical and Experimental Dermatology
|
September 4, 2020
The systemic autoinflammatory disorders for dermatologists. Part 2: disease examples
J Oldham, H J Lachmann
Clinical and Experimental Immunology
|
January 1, 1977
Haemolytic assays in agarose plates for components of the classical complement pathway: interference by the alternative pathway
A Martin, P J Lachmann
European Journal of Immunology
|
August 1, 1988
The regulation of IgG subclass production in man: low serum IgG4 in inherited deficiencies of the classical pathway of C3 activation
P Bird, P J Lachmann
European Journal of Immunology
|
March 1, 1975
The failure to show a necessary role for C3 in the in vitro antibody response
H Waldmann, P J Lachmann
Page
of 43